Global Autonomous Robotic Phlebotomy Device Market Strategic Research Report

Scope of the Report

The global Autonomous Robotic Phlebotomy Device market size is predicted to grow from US$ 3.06 million in 2025 to US$ 50.58 million in 2032; it is expected to grow at a CAGR of 39.4% from 2026 to 2032.

The Autonomous Robotic Phlebotomy Device is a medical robot system designed for hospital blood collection windows, medical examination centers, and pre-processing scenarios in medical laboratories. Its core capability is to use near-infrared and ultrasound technology to detect veins, reconstruct vein images using 3D technology, and then use AI algorithms to intelligently analyze the images, selecting the most appropriate location and method for needle insertion to achieve automated intravenous puncture blood testing. The system typically integrates identity verification, doctor's order matching, catheter and needle supply, disinfection, pulse pressure, quantitative blood collection, catheter replacement, mixing, hemostasis, and traceability recording, forming an auditable closed-loop blood collection workflow. This aims to improve the first-time puncture success rate, reduce pre-test errors, and alleviate the shortage of blood collection personnel. In 2025, the global production of Autonomous Robotic Phlebotomy Devices was approximately 32 units, with a unit price of approximately US$97,800 and a gross profit margin of approximately 45%–65%.

Currently, blood collection still faces many challenges, with poor visibility and inaccurate punctures being the main issues. Infants' blood vessels are very thin, and those with thicker fat layers or darker skin tones often have blood vessels that are difficult to visually assess. The failure rate for first-time intravenous punctures in children is around 44%, and repeated punctures increase the psychological stress on nurses. Due to various factors, the efficiency of blood collection and testing in many hospitals is not high. During peak blood collection periods, the average waiting time for patients is 24 minutes, with over 64.5% of patients waiting more than 15 minutes. Even in commercial medical examination institutions, the average time for a "trial" blood collection exceeds 10 minutes. From a clinical perspective, many hospitals face the pain point of high blood collection pressure, creating a significant demand for blood collection robots. Furthermore, the long-term shortage of nursing staff has spurred the need for "substitute labor." Currently, automation solutions exist for queuing, blood collection tube sorting, blood diagnosis, and report output; only the blood collection process still relies on manual labor. Future machine replacement will complete the automated closed loop of blood diagnosis. From the perspective of practical applications in healthcare, blood collection robots are still in their early stages of development. Due to factors such as cost and hospital procurement processes, their deployment is currently limited to large tertiary hospitals. Companies in this sector are primarily focused on research and development; future commercialization may require greater reliance on external Contract Sales Organizations (CSOs) to gradually penetrate hospitals. Globally, the European and American markets hold significant potential, as nurses in these countries have lower success rates with manual intravenous punctures, making them prime candidates for robot-assisted procedures. However, cost reduction is a key factor for commercialization. Currently, blood collection robots entering the market are expensive. Significant commercial and social value will only be realized after technological advancements and their integration into primary healthcare systems.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Autonomous Robotic Phlebotomy Device market?

What factors are driving Autonomous Robotic Phlebotomy Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Autonomous Robotic Phlebotomy Device market opportunities vary by end market size?

How does Autonomous Robotic Phlebotomy Device break out by Type, by Application?

This report presents a comprehensive overview of the global Autonomous Robotic Phlebotomy Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Fixed Kiosk Station
• Mobile Cart/Desktop Workstation

Segment by Modules

• Blood Collection and Puncture Module
• Multi-technology Modules

Segment by Sales Channel

• Direct Sales
• Distributor Sales

Segment by Application

• Hospital
• Health Checkup Center
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Autonomous Robotic Phlebotomy Device market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Health Checkup Center, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact